Search Results - "ROSEN, M. D"

Refine Results
  1. 1

    Hohlraum Reheating from Burning NIF Implosions by Rubery, M S, Rosen, M D, Aybar, N, Landen, O L, Divol, L, Young, C V, Weber, C, Hammer, J, Moody, J D, Moore, A S, Kritcher, A L, Zylstra, A B, Hurricane, O, Pak, A E, MacLaren, S, Zimmerman, G, Harte, J, Woods, T

    Published in Physical review letters (09-02-2024)
    “…As fusion experiments at the National Ignition Facility (NIF) approach and exceed breakeven, energy from the burning capsule is predicted to couple to the gold…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Targeted delivery of cytotoxic proteins to prostate cancer via conjugation to small molecule urea-based PSMA inhibitors by Rogers, O. C., Rosen, D. M., Antony, L., Harper, H. M., Das, D., Yang, X., Minn, I., Mease, R. C., Pomper, M. G., Denmeade, S. R.

    Published in Scientific reports (21-07-2021)
    “…Prostate cancer cells are characterized by a remarkably low proliferative rate and the production of high levels of prostate-specific proteases. Protein-based…”
    Get full text
    Journal Article
  4. 4

    Deletion of p53 in human mammary epithelial cells causes chromosomal instability and altered therapeutic response by Weiss, M B, Vitolo, M I, Mohseni, M, Rosen, D M, Denmeade, S R, Park, B H, Weber, D J, Bachman, K E

    Published in Oncogene (19-08-2010)
    “…The TP53 tumor suppressor gene is the most commonly mutated gene in human cancers. To evaluate the biological and clinical relevance of p53 loss, human somatic…”
    Get full text
    Journal Article
  5. 5

    Plasma-based beam combiner for very high fluence and energy by Kirkwood, R. K., Turnbull, D. P., Chapman, T., Wilks, S. C., Rosen, M. D., London, R. A., Pickworth, L. A., Dunlop, W. H., Moody, J. D., Strozzi, D. J., Michel, P. A., Divol, L., Landen, O. L., MacGowan, B. J., Van Wonterghem, B. M., Fournier, K. B., Blue, B. E.

    Published in Nature physics (01-01-2018)
    “…Extreme optical fluences, much beyond the damage threshold of conventional optics, are of interest for a range of high-energy-density physics applications…”
    Get full text
    Journal Article
  6. 6

    Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors by CONLEY, B. A, EGORIN, M. J, TAIT, N, ROSEN, D. M, SAUSVILLE, E. A, DOVER, G, FRAM, R. J, VAN ECHO, D. A

    Published in Clinical cancer research (01-03-1998)
    “…Butyrates have been studied as cancer differentiation agents in vitro and as a treatment for hemoglobinopathies. Tributyrin, a triglyceride with butyrate…”
    Get full text
    Journal Article
  7. 7

    Creation of hot radiation environments in laser-driven targets by Hinkel, D E, Schneider, M B, Young, B K, Langdon, A B, Williams, E A, Rosen, M D, Suter, L J

    Published in Physical review letters (19-05-2006)
    “…A hot radiation environment, produced by maximizing laser-energy deposition into a small, high- "can," is a platform being developed for investigations of…”
    Get full text
    Journal Article
  8. 8

    The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes : Evidence for in vivo biological activity by CLEMMONS, D. R, MOSES, A. C, MCKAY, M. J, SOMMER, A, ROSEN, D. M, RUCKLE, J

    “…Insulin-like growth factor-I (IGF-I) enhances insulin action in normal subjects and in patients with both type 1 and 2 diabetes; however, its administration is…”
    Get full text
    Journal Article
  9. 9

    Measurement of the absolute Hohlraum-Wall albedo under ignition foot drive conditions by JONES, O. S, GLENZER, S. H, ROSEN, M. D, WALLACE, R. J, WEBER, F. A, SUTER, L. J, TURNER, R. E, CAMPBELL, K. M, DEWALD, E. L, HAMMEL, B. A, HAMMER, J. H, KAUFFMAN, R. L, LANDEN, O. L

    Published in Physical review letters (06-08-2004)
    “…We present measurements of the absolute albedos of hohlraums made from gold or from high-Z mixtures. The measurements are performed over the range of radiation…”
    Get full text
    Journal Article
  10. 10

    Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations by EGORIN, M. J, ROSEN, D. M, WOLFF, J. H, CALLERY, P. S, MUSSER, S. M, EISEMAN, J. L

    Published in Cancer research (Chicago, Ill.) (01-06-1998)
    “…17-(Allylamino)-17-demethoxygeldanamycin (17AAG), a compound that is proposed for clinical development, shares the ability of geldanamycin to bind to heat…”
    Get full text
    Journal Article
  11. 11

    Phase I Study of Paclitaxel in Combination With a Multidrug Resistance Modulator, PSC 833 (Valspodar), in Refractory Malignancies by FRACASSO, P. M, WESTERVELDT, P, FEARS, C. A, ROSEN, D. M, ZUHOWSKI, E. G, CAZENAVE, L. A, LITCHMAN, M, EGORIN, M. J

    Published in Journal of clinical oncology (01-03-2000)
    “…To determine the maximum-tolerated dose (MTD), dose-limiting toxicity (DLT), and pharmacokinetics of paclitaxel when given with PSC 833 (valspodar) to patients…”
    Get full text
    Journal Article
  12. 12

    Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta by Seyedin, S M, Thompson, A Y, Bentz, H, Rosen, D M, McPherson, J M, Conti, A, Siegel, N R, Galluppi, G R, Piez, K A

    Published in The Journal of biological chemistry (05-05-1986)
    “…Comparison of the sequence of the N-terminal 30 amino acids of cartilage-inducing factor-A (CIF-A) from bovine demineralized bone with the corresponding…”
    Get full text
    Journal Article
  13. 13

    A fragment of the hypophosphatemic factor, MEPE, requires inducible cyclooxygenase-2 to exert potent anabolic effects on normal human marrow osteoblast precursors by Nagel, D.E., Khosla, S., Sanyal, A., Rosen, D.M., Kumagai, Y., Riggs, B. Lawrence

    Published in Journal of cellular biochemistry (15-12-2004)
    “…MEPE, 56.6 kDa protein isolated from tumors associated with hypophosphatemic osteomalacia, increases renal phosphate excretion and is expressed in normal human…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Cartilage-inducing factor-B is a unique protein structurally and functionally related to transforming growth factor-beta by Seyedin, S.M., Segarini, P.R., Rosen, D.M., Thompson, A.Y., Bentz, H., Graycar, J.

    Published in The Journal of biological chemistry (15-02-1987)
    “…Cartilage-inducing factors-A (CIF-A) and -B (CIF-B), purified from bovine bone on the basis of their ability to induce the cartilage phenotype in vitro, are…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Ultrafast X-Ray Pulses from Laser-Produced Plasmas by Murnane, Margaret M., Kapteyn, Henry C., Rosen, Mordecai D., Falcone, Roger W.

    “…A high-temperature plasma is created when an intense laser pulse is focused onto the surface of a solid. An ultrafast pulse of x-ray radiation is emitted from…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Demonstration of a soft X-ray amplifier by MATTHEWS, D. L, HAGELSTEIN, P. L, CAMPBELL, E. M, HATCHER, C. W, HAWRYLUK, A. M, KAUFFMAN, R. L, PLEASANCE, L. D, RAMBACH, G, SCOFIELD, J. H, STONE, G, WEAVER, T. A, ROSEN, M. D, ECKART, M. J, CEGLIO, N. M, HAZI, A. U, MEDECKI, H, MCGOWAN, B. J, TREBES, J. E, WHITTEN, B. L

    Published in Physical review letters (14-01-1985)
    “…Observations of amplified spontaneous emission at soft X-ray wavelengths are reported. An optical laser ionized thin foils of selenium to produce a population…”
    Get full text
    Journal Article